Future studies should investigate the pharmacokinetics of adenosine, AMP, cyclic AMP, ADP, and ATP in tumor cells and immune cells to understand how the CD39/CD73/A2AR pathway in the tumor microenvironment plays a role in how cancer cells survive and escape the anti-tumor immune response. The gene discussed is ENTPD1; the disease is cancer.